Gregory R. Bluemling

An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice

Timothy P. Sheahan, Amy Sims, Shuntai Zhou et al. · Science Translational Medicine · 2020 · 1.1K citations · Full text

SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801

Angela Wahl, Lisa E. Gralinski, Claire Johnson et al. · Nature · 2021 · 418 citations · Full text

Covid-19 Pandemic, Covid-19, Sars-cov-2 Infection

Small-Molecule Antiviral β- <scp>d</scp> - <i>N</i> ⁴ -Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance

Maria L. Agostini, Andrea J. Pruijssers, James D. Chappell et al. · Journal of Virology · 2019 · 344 citations · Full text

Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia

Märt Toots, Jeong-Joong Yoon, Robert M. Cox et al. · Science Translational Medicine · 2019 · 332 citations · Full text

4′-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication

Julien Sourimant, Carolin M. Lieber, Megha Aggarwal et al. · Science · 2022 · 118 citations · Full text

Oral Antiviral, Respiratory Virus Immunity, Viral Polymerase Structure +17